Atwood & Palmer’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $82.9K | Hold |
916
| – | – | ﹤0.01% | 211 |
|
|
2026
Q1 | $73.4K | Buy |
916
+4
| +0.4% | +$330 | ﹤0.01% | 220 |
|
|
2025
Q4 | $77.7K | Hold |
912
| – | – | ﹤0.01% | 204 |
|
|
2025
Q3 | $70.9K | Hold |
912
| – | – | ﹤0.01% | 218 |
|
|
2025
Q2 | $71.3K | Hold |
912
| – | – | ﹤0.01% | 216 |
|
|
2025
Q1 | $66.1K | Hold |
912
| – | – | ﹤0.01% | 206 |
|
|
2024
Q4 | $67.5K | Hold |
912
| – | – | ﹤0.01% | 205 |
|
|
2024
Q3 | $60.2K | Hold |
912
| – | – | ﹤0.01% | 211 |
|
|
2024
Q2 | $84.2K | Hold |
912
| – | – | 0.01% | 197 |
|
|
2024
Q1 | $87.2K | Hold |
912
| – | – | 0.01% | 193 |
|
|
2023
Q4 | $69.5K | Hold |
912
| – | – | 0.01% | 207 |
|
|
2023
Q3 | $63.2K | Hold |
912
| – | – | 0.01% | 202 |
|
|
2023
Q2 | $86K | Hold |
912
| – | – | 0.01% | 197 |
|
|
2023
Q1 | $75.5K | Hold |
912
| – | – | 0.01% | 188 |
|
|
2022
Q4 | $68K | Hold |
912
| – | – | 0.01% | 196 |
|
|
2022
Q3 | $75K | Sell |
912
-202
| -18% | -$19.4K | 0.01% | 183 |
|
|
2022
Q2 | $106K | Buy |
1,114
+202
| +22% | +$20.9K | 0.01% | 162 |
|
|
2022
Q1 | $107K | Hold |
912
| – | – | 0.01% | 175 |
|
|
2021
Q4 | $118K | Hold |
912
| – | – | 0.01% | 174 |
|
|
2021
Q3 | $103K | Hold |
912
| – | – | 0.01% | 185 |
|
|
2021
Q2 | $94K | Hold |
912
| – | – | 0.01% | 189 |
|
|
2021
Q1 | $76K | Hold |
912
| – | – | 0.01% | 196 |
|
|
2020
Q4 | $83K | Hold |
912
| – | – | 0.01% | 183 |
|
|
2020
Q3 | $73K | Hold |
912
| – | – | 0.01% | 173 |
|
|
2020
Q2 | $63K | Hold |
912
| – | – | 0.01% | 177 |
|
|
2020
Q1 | $57K | Hold |
912
| – | – | 0.01% | 172 |
|
|
2019
Q4 | $71K | Hold |
912
| – | – | 0.01% | 169 |
|
|
2019
Q3 | $67K | Hold |
912
| – | – | 0.01% | 178 |
|
|
2019
Q2 | $56K | Hold |
912
| – | – | 0.01% | 170 |
|
|
2019
Q1 | $58K | Hold |
912
| – | – | 0.01% | 169 |
|
|
2018
Q4 | $47K | Hold |
912
| – | – | 0.01% | 172 |
|
|
2018
Q3 | $53K | Hold |
912
| – | – | 0.01% | 178 |
|
|
2018
Q2 | $44K | Hold |
912
| – | – | 0.01% | 184 |
|
|
2018
Q1 | $42K | Hold |
912
| – | – | 0.01% | 185 |
|
|
2017
Q4 | $34K | Hold |
912
| – | – | ﹤0.01% | 197 |
|
|
2017
Q3 | $33K | Hold |
912
| – | – | ﹤0.01% | 199 |
|
|
2017
Q2 | $36K | Hold |
912
| – | – | 0.01% | 202 |
|
|
2017
Q1 | $29K | Buy |
912
+312
| +52% | +$9.77K | ﹤0.01% | 198 |
|
|
2016
Q4 | $19K | Buy |
+600
| New | +$19.4K | ﹤0.01% | 233 |
|
Other funds holding EW
WT
BHIA
NONA
SIM
AAIS
Atwood & Palmer's EW Position: Q2 2026 in Review
Atwood & Palmer held its Edwards Lifesciences (EW) position steady in Q2 2026 at 916 shares worth $82.9K. The position accounts for ﹤0.01% of the portfolio, ranked #211.
Atwood & Palmer first reported a position in EW in Q4 2016 and has held it in 39 quarters since. The position peaked at $118K in Q4 2021. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Atwood & Palmer held 916 shares of Edwards Lifesciences worth $82.9K as of Q2 2026.
- Atwood & Palmer left its Edwards Lifesciences share count unchanged in Q2 2026.
- Edwards Lifesciences made up ﹤0.01% of Atwood & Palmer's portfolio in Q2 2026, its #211 holding.
- Atwood & Palmer first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 39 quarters since.
- Atwood & Palmer's Edwards Lifesciences position peaked at $118K in Q4 2021.
- 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.